PTEN and non-small cell lung carcinoma: In this study, we aimed to develop this treatment paradigm in models representing patients with a loss of PTEN, a multifunctional tumour suppressor gene that is commonly downregulated in NSCLC and associated with radioresistance and, ultimately, poor clinical outcomes [14].